NEURO-DEGENERATIVE DISEASE
Clinical trials for NEURO-DEGENERATIVE DISEASE explained in plain language.
Never miss a new study
Get alerted when new NEURO-DEGENERATIVE DISEASE trials appear
Sign up with your email to follow new studies for NEURO-DEGENERATIVE DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for rare immune cell diseases: targeted drug trial opens
Disease control Recruiting nowThis study tests a drug called cobimetinib in children and adults with Langerhans cell histiocytosis and related disorders that have not responded to standard treatment or have returned. Cobimetinib blocks a faulty growth signal in the disease cells. The goal is to see if the dru…
Matched conditions: NEURO-DEGENERATIVE DISEASE
Phase: PHASE2 • Sponsor: Carl Allen • Aim: Disease control
Last updated Apr 28, 2026 13:02 UTC
-
Researchers launch first natural history study for rare nerve disease CMT4J
Knowledge-focused Recruiting nowThis study follows 20 people with a confirmed diagnosis of CMT4J, a rare nerve disease, for up to 2 years. Participants will have check-ups once a year to track how the disease progresses. The goal is to better understand CMT4J and find better ways to measure it in future studies…
Matched conditions: NEURO-DEGENERATIVE DISEASE
Sponsor: Elpida Therapeutics SPC • Aim: Knowledge-focused
Last updated Apr 28, 2026 13:11 UTC